Showing 7681-7690 of 9449 results for "".
Psoriasis and Inflammatory Disease Management Today
https://practicaldermatology.com/topics/psoriasis/psoriasis-and-inflammatory-disease-management-today/19885/COVID-19 can have implications for psoriasis management. Jashin Wu, MD, founder of San Diego Dermatology Symposium, provides guidance on management and introduces the Inaugural Symposium for Inflammatory Skin Disease, coming virtually in April.Scientifically Speaking: Botulinum Toxin Formulation and Testing
https://practicaldermatology.com/videos/scientifically-speaking/scientifically-speaking-botulinum-toxin-formulation-and-testing/19832/Ever wonder about the differences in formulation and manufacture of botulinum neurotoxins? Curious about the trials that support approval? In this edition of Scientifically Speaking, Joel L. Cohen, MD gets the answers to these questions and more from Conor Gallagher, PhD, Head of Medical Affairs, ReEvolutions and Revolutions in HS
https://practicaldermatology.com/topics/rare-disease/evolutions-and-revolutions-in-hs/19726/The past decade has seen significant advances in the understanding of hidradenitis suppurativa pathogenesis, informing research into novel treatment approaches, such as biologics, and expanded indications for existing pharmacologic agents. Ali Alikhan, MD reviews the evolving landscape in HS and revIndian Innovations
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/indian-innovations/19709/Dermatologic innovations from India date back to BCE. Chytra Anand, MD shares insights on mangaing pigmentation and more.Improving Mastectomy Scars with the Vbeam Prima
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/improving-mastectomy-scars-with-the-vbeam-prima/19692/Many women with breast cancer will undergo a mastectomy, resulting in major scarring on the breasts. Jill Waibel, MD is passionate about helping these women get the treatment they deserve post-surgery and uses the Vbeam Prima, a pulsed dye laser device, to help improve the appearance of the scars. WChin Up
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/chin-up/19689/Placement of a small volume of filler in the chin can be the secret to creating an ideal aesthetic in the lower face, according to Sabrina Fabi, MD. She discusses the anatomy of the face and explains why this approach can be so successful.Cosmetic Bootcamp 2019: Presenter Recaps
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/cosmetic-bootcamp-2019-presenter-recaps/19631/In its 15th year, Cosmetic Bootcamp continues to bring together core aesthetic physicians to earn about new and emerging interventions. Mary Lupo, MD; Jeanine Downie, MD; Jose Raul Montes, MD; Diane Berson, MD; Ava Shamban, MD; and Deborah Sherman, MD recap their presentations.Thread Lifting 4.0
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/thread-lifting-40/19603/Today’s thread lifts bring more to the table than previous iterations. Older threads lifted sagging facial tissue, but now they are absorbable and biostimulatory, which means they can lift and add volume to the face and also aid in scar remodelling, explains Hooman Khorasani, MD.Updates from Principia, Sebacia, and Candela
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-updates-from-principia-sebacia-and-candela/19571/Phase 2 data for from the Believe-PV study for PRN1008 show that the investigational agent from Principia Biopharma reached the primary efficacy measure in pemphigus. Data confirm that Sebacia microparticles confer benefit in the management of acne vulgaris in real-world settings. Candela has rebranGuidelines for PsO, SRT; Promising Data from Sienna
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-guidelines-for-pso-srt-promising-data-from-sienna/19551/Two new guidelines from the American Academy of Dermatology and the National Psoriasis Foundation outline best practices for treating psoriasis, with a focus on comorbidities and biologic treatment. A new retrospective study shows a cure rate above 97 percent among older patients treated with superf